Senior insider sale
General Counsel at UROGEN PHARMA LTD. — senior position signals high conviction
$67.0K
1.52K shares
What this filing means
SMITH JASON DREW plans to sell 1.52K shares of UROGEN PHARMA LTD. valued at approximately $67.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2026ACC: 0001976408-26-000810
Officer· General Counsel
Since Aug 2020
1.52K
Shares to sell
$67.0K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
9/8/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2026 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
1.52K
Market value
$67.0K
9/8/2026
Total
Units
1.52K
Value
$67.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/8/2026 | 1.52K | $67.0K | Nasdaq | Planned |
| Total | 1.52K | $67.0K | ||